The requirements for protection of human subjects and procedures for Institutional Review Boards are outlined in 21 CFR § 50 and 56.
Good Clinical Practices
Share / Follow
Recent Blogs
Evolution of an Assay
Could this also be a revolution in FDA thinking?
Good Grief! FDA's Latest LDT Announcements
Here we go again...
Looking Back on the IVD Hall of Fame
Even if it's not your list, here's no denying their impact on the practice of medicine
Allomap
Making a difference in the lives of heart transplant patients